Announce Date | 05/05/2025 |
EPS Normalized Actual | $-0.03 (Beat by $0.08) |
EPS GAAP Actual | $-0.03 (Beat by $0.08) |
Revenue Actual | $0.8266B |
Revenue Surprise | Beat by $826.6M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 1.79 | 10.88 | 1.74065 | 1.81418 | 1 |
Dec 2025 | 1.61667 | 12.04 | 1.48 | 1.77 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 0.8266B | 2.07% | 826.6M |
FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 1.6464B | 1.56% | 1646.4M |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 1.84386B | -4.06% | 1843.86M |
FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 1.0797B | -0.69% | 1079.7M |
FQ1 2024 (Mar 2024) | -0.0816 | -0.0816 | 0.8095B | -0.63% | 809.5M |
FQ4 2023 (Dec 2023) | 0.42 | 0.42 | 1.6207B | 13.5% | 1620.7M |
FQ3 2023 (Sep 2023) | 0.41 | 0.41 | 1.9188B | 8.49% | 1918.8M |
FQ2 2023 (Jun 2023) | 0.08 | 0.08 | 1.0872B | -13.66% | 1087.2M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.42807 | -- | 0.40267 | 0.45332 | 2 |
FQ3 2027 (Sep 2027) | 1.31984 | -- | 1.24154 | 1.39769 | 2 |
FQ2 2027 (Jun 2027) | 0.24073 | -- | 0.22645 | 0.25493 | 2 |
FQ1 2027 (Mar 2027) | -0.10801 | -- | -0.11438 | -0.1016 | 2 |
FQ4 2026 (Oct 2026) | 1.13197 | -- | 1.06096 | 1.19305 | 3 |
FQ3 2026 (Jul 2026) | 0.24127 | -- | 0.22614 | 0.25429 | 5 |
FQ2 2026 (Jun 2026) | 0.24127 | -- | 0.2245 | 0.25442 | 5 |
FQ1 2026 (Mar 2026) | -0.13569 | 11.56 | -0.14308 | -0.12626 | 3 |
FQ4 2025 (Oct 2025) | 1.01895 | 59.76 | 0.95503 | 1.07393 | 4 |
FQ3 2025 (Jul 2025) | 0.19957 | -446.17 | 0.18705 | 0.21034 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.71B | -- | 1.63B | 1.79B | 3 |
FQ3 2027 (Sep 2027) | 1.91B | -- | 1.83B | 2B | 3 |
FQ2 2027 (Jun 2027) | 1.16B | -- | 1.11B | 1.21B | 3 |
FQ1 2027 (Mar 2027) | 0.78B | -- | 0.74B | 0.81B | 3 |
FQ4 2026 (Oct 2026) | 1.94B | -- | 1.84B | 2.02B | 4 |
FQ3 2026 (Jul 2026) | 1.2B | -- | 1.14B | 1.25B | 5 |
FQ2 2026 (Jun 2026) | 1.2B | -- | 1.13B | 1.25B | 6 |
FQ1 2026 (Mar 2026) | 0.89B | 7.48 | 0.85B | 0.93B | 4 |
FQ4 2025 (Oct 2025) | 1.93B | 14.9 | 1.84B | 2.01B | 2 |
FQ3 2025 (Jul 2025) | 1.12B | -65.06 | 1.06B | 1.16B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 100% | |
FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 100% | |
FQ2 2024 (Jun 2024) | 0.17 | 0.17 | 100% | |
FQ1 2024 (Mar 2024) | -0.0816 | -0.0816 | 100% | |
FQ4 2023 (Dec 2023) | 0.42 | 0.42 | 100% | |
FQ3 2023 (Sep 2023) | 0.41 | 0.41 | 100% | |
FQ2 2023 (Jun 2023) | 0.08 | 0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.83B | $826.6M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.65B | $1646.4M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.84B | $1843.86M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.08B | $1079.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.81B | $809.5M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.62B | $1620.7M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.92B | $1918.8M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.09B | $1087.2M | 100% |